Latest Retina News

We’re Now In Port Orange!

Central Florida Retina Port Orange Location Announcement

Great News! Central Florida Retinal is now in Port Orange! Central Florida Retina714 Dunlawton AvePort Orange, FL 32127

Read More

Central Florida Retina Orlando Has A New Home!

New Orlando Location Announcement

Our doctors and staff look forward to seeing our valued patients at our new office beginning August 3rd, 2020. 3824 Oakwater CircleOrlando, FL 32806

Read More

We’re Here For You

Were Here For You

Dear Valued Patients & Ophthalmic Community, The CFR team is committed to continue serving you during the COVID-19 pandemic. For everyone’s protection, we have instituted strict safety guidelines at all of our facilities as recommended by the CDC. Please don’t hesitate to reach to us if you need our services. Stay safe!

Read More

A Message For Our Valued Patients During The Coronavirus Pandemic

Coronavirus Message

“Your safety and well-being are a top concern at Central Florida Retina.”

Read More

Welcome Dr. William J. Carroll

Welcome Dr. Carroll

Central Florida Retina is proud to welcome Dr. William J. Carroll to our team of Physicians.

Read More

August News: New Retina Specialist & New Offices

Summer Newsletter Page 1

Central Florida Retina Newsletter, Summer 2018.

Read More

Eric G. Feinstein, M.D. Joins Central Florida Retina Fall 2018

Welcome Dr. Feinstein

Central Florida Retina is proud to welcome Eric G. Feinstein, M.D. Accepting patients in August, 2018.

Read More

Dr. Gokul Kumar On The News Discussing The Solar Eclipse & How To Protect Your Eyes

News Show Screen Shot

Click Here To Watch The Video on Facebook

Read More

A Message From Dr. Barnes

Message From Dr. Barnes

A message from Central Florida Retina’s Founding Partner.

Read More

Panorama Study For Patients With Diabetic Retinopathy

Panorama Study For Patients With Diabetic Retinopathy

Clinical Trial for Patients with NPDR Dear Respected Colleague, We are pleased to inform you that CFR is participating as a recruiting study site in the Regeneron Pharmaceuticals, Inc. PANORAMA study: a phase 3 study of the efficacy and safety of intravitreal (IVT) aflibercept in patients with moderately severe to severe NPDR. Approximately 360 patients […]

Read More

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.